News
Detailed price information for Appili Therapeutics Inc (APLI-T) from The Globe and Mail including charting and trades.
The timing is fortuitous for Chinese AI companies which have been left scrambling for domestic alternatives to the H20, the primary AI chip that Nvidia had until recently been allowed to sell ...
APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced that its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results